Socioeconomic implications of pediatric cervical methicillin-resistant Staphylococcus aureus infections

Michael E McCormick1, Robert H Chun, Lina Lander

  • 1Department of Otolaryngology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. mmccormick@mcw.edu

Insights

Cervical methicillin-resistant Staphylococcus aureus (MRSA) infections disproportionately affect younger children and those from lower socioeconomic backgrounds, leading to significant healthcare resource utilization and disparities in care.

Area of Science:

  • Pediatric Infectious Diseases
  • Healthcare Disparities
  • Public Health Surveillance

Background:

  • Cervical methicillin-resistant Staphylococcus aureus (MRSA) infections pose a significant challenge in pediatric care.
  • Understanding resource utilization is crucial for optimizing treatment strategies and healthcare costs.

Purpose of the Study:

  • To establish normative data for pediatric cervical MRSA infections.
  • To identify variations in healthcare resource utilization based on patient demographics and socioeconomic factors.

Main Methods:

  • Retrospective analysis of the Kids' Inpatient Database 2009.
  • Inclusion of pediatric admissions with MRSA and specific head and neck infections using ICD-9-CM codes.

Main Results:

  • Over 3500 pediatric cases of cervical MRSA infections were identified.
  • Patients were predominantly from lower socioeconomic quartiles, with Medicaid as the primary payer.
  • Younger children experienced longer hospital stays and higher rates of surgical intervention.

Conclusions:

  • Cervical MRSA infections have a substantial socioeconomic impact, with notable racial and age-related differences in resource utilization.
  • Targeted clinical interventions are needed to improve care for vulnerable pediatric populations affected by these infections.
Abstract

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...